Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | LPL | P06858 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22045767 | 0.85 | LIPG (0.39) | CSF1RLPLLIPG | |
| SCHEMBL24698693 | 0.85 | LIPG (0.46) | CSF1RLPLLIPG | |
| SCHEMBL22045661 | 0.84 | LIPG (0.49) | CSF1RLPLLIPG | |
| SCHEMBL22045686 | 0.84 | CSF1R (0.32) | CSF1RLPLLIPG | |
| SCHEMBL22045682 | 0.84 | LPL (0.40) | LPLLIPG | |
| SCHEMBL22045387 | 0.83 | LIPG (0.37) | CSF1RLPLLIPG | |
| SCHEMBL22044936 | 0.82 | CSF1R (0.35) | CSF1RLPLLIPG | |
| SCHEMBL22045389 | 0.81 | LIPG (0.39) | CSF1RLPLLIPG | |
| SCHEMBL22045766 | 0.78 | LPL (0.37) | LPLLIPG | |
| SCHEMBL22045688 | 0.77 | LPL (0.34) | CSF1RLPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512076-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-11-29 | — | — | US | disclosed |
| US-20200172524-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512076-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | PIEZO1, OCIAD1, LEF1 | CSF1R 3844/4885LPL 3024/4885LIPG 1174/4885 |
| US-20200172524-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | CSF1R 3844/4885LPL 3024/4885LIPG 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.